What is PTHS's dilution risk score?

PTHS has a latest available DilutionScore record of 69/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PTHS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PTHS?

DilutionWatch tracks 25 SEC filing types for PTHS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PTHS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PTHS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PTHS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PTHS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PTHS Dilution Risk Score: 69/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

25

📊 Float Risk

80

⚠️ Warrant Exposure

40

🔄 Convertible Debt

60

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 23%

🔁 Convertible Conversion model 40%

• Significant convertible debt: 19% potential dilution

• Elevated convertible risk (60/100)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (69/100)

🔔 Track PTHS — Get forecast alerts →

Market Data

Market Cap$92.00M

Shares Outstanding3.83M

Float1.47M

Cash$24.19M

Debt$52.93M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 11.5% shares (2026Q1 vs prior)

17 institutional holders · 1.01M shares

#1 Murchinson Ltd. 296.3K shares

#2 Ikarian Capital, LLC 256.6K shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 186.2K shares

+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest69.5K

Days to Cover1.0

% of Float4.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31

xbrl XBRL CONVERTIBLE 2025-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PTHS Dilution Snapshot

Pelthos Therapeutics Inc. (PTHS) has a DilutionScore of 69/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for PTHS: xbrl on 2026-03-31; xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.